Arylosulfonamides for the treatment of CNS diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8822517
APP PUB NO 20130172365A1
SERIAL NO

13824066

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ADAMED SP Z O O05-152 CZOSNÓW K/WARSZAWY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bucki, Adam Proszowice, PL 9 4
Jaśkowska, Jolanta Kraków, PL 2 1
Kolaczkowski, Marcin Wieliczka, PL 7 4
Kowalski, Piotr Kraków, PL 3 3
Marcinkowska, Monika Kraków, PL 8 4
Mitka, Katarzyna Kraków, PL 2 1
Pawlowski, Maciej Wieliczka, PL 7 3
Wesolowska, Anna Kraków, PL 5 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 2, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00